CMS proposes new hospital reimbursement rate for CAR Ts

CMS has proposed to increase the rate at which it reimburses hospitals for ancillary costs associated with hospital stays for CAR T therapies.

In an April 24 memo on its proposed FY19 Medicare hospital inpatient prospective payment rule, CMS said it is seeking comment on a proposal to assign a higher weighted Medicare Severity Diagnosis Related Groups (MS-DRG) payment classification for CAR T cell therapies...